Clinical Study
Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma
Table 5
Multivariate logistic regression analyses of factors predicting recurrences.
| Factor | Odds ratio | 95% CI | P value |
| Overall tumor recurrences | | | | Age (>60 years) | 1.300 | 0.619–2.729 | 0.489 | Histology* | 1.092 | 0.556–2.147 | 0.798 | FIGO grade (3 versus 1-2) | 3.726 | 1.957–7.095 | 0.00006 | Nuclear grade (3 versus 1-2) | 1.713 | 0.878–3.341 | 0.114 | DNA ploidy** | 1.669 | 1.071–2.602 | 0.024 | Myometrial infiltration*** | 2.077 | 1.392–3.098 | 0.0003 |
| Distant tumor recurrences | | | | Age (>60 years) | 0.844 | 0.377–1.889 | 0.680 | Histology* | 1.155 | 0.572–2.330 | 0.689 | FIGO grade (3 versus 1-2) | 4.750 | 2.319–9.729 | 0.00002 | Nuclear grade (3 versus 1-2) | 1.686 | 0.809–3.515 | 0.163 | DNA ploidy** | 1.805 | 1.101–2.957 | 0.019 | Myometrial infiltration*** | 2.853 | 1.784–4.565 | 0.00001 |
|
|
*Nonendometrioid versus endometrioid. **Nondiploid versus diploid. ***>50% versus <50%.
|